This episode, Ben Stevens, Director of CMC Policy and Advocacy with GSK, and Eric Staib, Vice President of Corporate Quality with Syneos, join the podcast to share more about the current state of AI in the pharmaceutical industry, key AI-related challenges and opportunities facing the industry, and the work they’re doing on ISPE’s recently established Artificial Intelligence Community of Practice to help support the industry in navigating the rapid proliferation of AI.

This episode, Ben Stevens, Director of CMC Policy and Advocacy with GSK, and Eric Staib, Vice President of Corporate Quality with Syneos, join the podcast to share more about the current state of AI in the pharmaceutical industry, key AI-related challenges and opportunities facing the industry, and the work they’re doing on ISPE’s recently established Artificial Intelligence Community of Practice to help support the industry in navigating the rapid proliferation of AI. 

This episode, Takeda’s Senior Vice President, Head of Global Quality Compliance and Systems, Magaly Aham, joins the podcast to discuss how AI can enable sustainable quality transformation. She’ll touch on Takeda’s unique approach to leveraging AI, share a few key case study examples, and elaborate on how she envisions their work will help to move the industry forward.

This episode, Takeda’s Senior Vice President, Head of Global Quality Compliance and Systems, Magaly Aham, joins the podcast to discuss how AI can enable sustainable quality transformation. She’ll touch on Takeda’s unique approach to leveraging AI, share a few key case study examples, and elaborate on how she envisions their work will help to move the industry forward.

Mike Martin, President and CEO of ISPE, joins ISPE’s podcast host Robert Chew for this first episode to discuss the current pharmaceutical landscape, how the industry is responding to new challenges and opportunities, where he sees the industry going in the next five years, and more.